Clinical trial
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
NCT00160654 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00160654 |
|---|---|
| Title | Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy |
| Official title | A Phase IV, Open-label, Multi-center, Community-based Trial in Asia Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 251 |
| Start date | Nov 24, 2003 |
| Primary completion | Dec 12, 2006 |
| Completion | Dec 12, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 19, 2020 |
| Countries | Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: